Rescue for Emergency Surgery Patients Observed to uNdergo Acute Deterioration (RESPOND)

June 8, 2021 updated by: University of Oxford

RESPOND Study (Rescue for Emergency Surgery Patients Observed to uNdergo Acute Deterioration)

This is a Five Year programme designed to identify and evaluate human factors interventions to improve the response to patients deteriorating following emergency surgery.

The programme comprises four work packages:

Work Package 1: Qualitative interviews and observations to analyse current rescue systems; Work Package 2: Identify and co-design interventions to improve rescue systems,involving both staff and patients and carers; Work Package 3: Mixed-methods feasibility trial across 3 sites in England, Work Package 4: Step-wedge randomised control trial based across 24 hospital sites in England, evaluating efficacy of interventions in improving response to deteriorating patients.

Study Overview

Detailed Description

Patient safety researchers study problems in healthcare systems which harm patients. The investigators wish to study a healthcare situation where system problems are costing lives. In Emergency General Surgery (EGS), dealing mainly with patients with severe abdominal pain, the death rate after abdominal surgery to find out what's wrong (called 'laparotomy') is 5 times higher than for similar routine surgery. Studies of serious complications after major operations show that when patients deteriorate after surgery, their chances of survival depend on how quickly and how well clinical teams react. The investigators plan to analyse how EGS teams currently treat deteriorating patients, and help them develop and test better response systems. Up to 3000 deaths per year could be avoided if these systems were improved . Human Factors science analyses how complex work systems succeed or fail, and how to improve them. The investigators will conduct a Human Factors analysis of real life responses to deterioration in EGS laparotomy patients, examining how staff actually deal with deteriorating patients (referred to as "work as done"), and how this differs from official guidelines (referred to as "work as imagined"). A modern approach to Human Factors called "Safety II" studies both strengths and weaknesses of systems to design solutions. The investigators will use this method to analyse current EGS rescue systems, and develop a new system for managing deterioration, including ways of involving patients or carers effectively. The investigators will test and modify this system until it can be shown that it improves team performance during rescue. Once it appears stable and effective, the investigators will test it in a multi-hospital trial. Hospitals will start using the new system at different dates (decided by chance), and the investigators will compare their performance before and after they start.

The investigators will study the cost-effectiveness of the intervention and analyse what worked well and why, to make sure the lessons are learned effectively.

Study Type

Interventional

Enrollment (Anticipated)

9064

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Stoke Mandeville, United Kingdom
        • Recruiting
        • Buckinghamshire Healthcare NHS Trust
        • Contact:
          • Rame Sunthareswaran
        • Principal Investigator:
          • Rame Sunthareswaran
    • Oxfordshire
      • Oxford, Oxfordshire, United Kingdom, OX3 9DU
        • Recruiting
        • Professor Peter McCulloch
        • Contact:
          • Peter McCulloch
        • Principal Investigator:
          • Giles Bond-Smith

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Senior Medical staff in EGS and in other departments and disciplines with important roles in rescue (Anaesthetics, Gastroenterology, Interventional Radiology, Intensive Treatment Unit)
  • Junior medical staff in EGS (First Year 1 and 2, Core trainee and Surgical Trainee 3 + grades)
  • Senior nursing staff in EGS and other relevant departments (Theatres, Intensive Treatment Unit/outreach)
  • Recovered patients or their carers

Exclusion Criteria:

  • Patients lacking mental capacity
  • Patients who cannot communicate in English AND for whom translation facilities cannot be secured
  • Patients with documented PTSD (Post Traumatic Stress Disorder) related to their experience of complications after laparotomy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Human Factors Interventions
A 'bundle' of human factors interventions designed to improve response to deteriorating patients.
The group will use semi-structured interviews and ethnographic observations to inform development of a Functional Resonance Analysis Method (FRAM) model of the process for rescue of deteriorating patients in EGS, using information from 3 hospitals. A focus group approach will be used in co-designing reform of the system for responding to post-operative deterioration, working with small groups of frontline clinical staff from relevant areas in the three Trusts involved.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improvement in response to deterioration
Time Frame: 12 months
Reduction in ratio of mortality to complications
12 months
Improved Effectiveness of response to deterioration
Time Frame: 12 months
Number, severity and duration of Modified Early Warning Score (MEWS) system alerts,
12 months
Improved Effectiveness of response to deterioration
Time Frame: 12 months
Average timings for initial response to MEWS triggers
12 months
Improved Effectiveness of response to deterioration
Time Frame: 12 months
Average timings for the segments of the MEWS response process
12 months
Improved quality of response to deterioration
Time Frame: 12 months
Qualitative interview data with senior surgeons showing comparison of response quality and success in cases where patient or carer alerts were present with those where they were not
12 months
Improved effectiveness of response to deterioration
Time Frame: 12 months
Number of specialist interventions following emergency laparotomy
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improvement in mortality of emergency laparotomy patients
Time Frame: 12 months
reduction in mortality of emergency laparotomy patients
12 months
Improvement in recovery of emergency laparotomy patients
Time Frame: 12 months
Reduction in ITU stay and overall hospital stay
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 5, 2021

Primary Completion (Anticipated)

February 28, 2026

Study Completion (Anticipated)

February 28, 2026

Study Registration Dates

First Submitted

March 22, 2021

First Submitted That Met QC Criteria

June 8, 2021

First Posted (Actual)

June 9, 2021

Study Record Updates

Last Update Posted (Actual)

June 9, 2021

Last Update Submitted That Met QC Criteria

June 8, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emergencies

Clinical Trials on FRAM Model and Human Factors/Quality Improvement Intervention

3
Subscribe